COX6A1
Cytochrome c oxidase subunit 6A1, mitochondrial
Also known as: COX6A, COX6AL, CX6A1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P12074
- Gene
- COX6A1
- Ensembl
- ENSG00000111775
- Chromosome
- 12
- Canonical length
- 109 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Mitochondria,Principal piece
OverviewNCBI Gene
Cytochrome c oxidase (COX), the terminal enzyme of the mitochondrial respiratory chain, catalyzes the electron transfer from reduced cytochrome c to oxygen. It is a heteromeric complex consisting of 3 catalytic subunits encoded by mitochondrial genes and multiple structural subunits encoded by nuclear genes. The mitochondrially-encoded subunits function in the electron transfer and the nuclear-encoded subunits may function in the regulation and assembly of the complex. This nuclear gene encodes polypeptide 1 (liver isoform) of subunit VIa, and polypeptide 1 is found in all non-muscle tissues. Polypeptide 2 (heart/muscle isoform) of subunit VIa is encoded by a different gene, and is present only in striated muscles. These two polypeptides share 66% amino acid sequence identity. It has been reported that there may be several pseudogenes on chromosomes 1, 6, 7q21, 7q31-32 and 12. However, only one pseudogene (COX6A1P) on chromosome 1p31.1 has been documented. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
109 residues, UniProt reviewed canonical sequence.
>P12074|COX6A1
1 MAVVGVSSVS RLLGRSRPQL GRPMSSGAHG EEGSARMWKT LTFFVALPGV AVSMLNVYLK
61 SHHGEHERPE FIAYPHLRIR TKPFPWGDGN HTLFHNPHVN PLPTGYEDELocalizationUniProt · AlphaFold · HPA
Whether an antibody against COX6A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 1,832 nTPM
Expression across tissuesHPA
Tissue
- amygdala: 1,832 nTPM
- midbrain: 1,427 nTPM
- cerebral cortex: 1,404 nTPM
- hippocampal formation: 1,237 nTPM
- basal ganglia: 988 nTPM
- hypothalamus: 930 nTPM
Single-cell type
- parietal cells: 911 nCPM
- enterocytes: 444 nCPM
- colonocytes: 296 nCPM
- enteric transient amplifying cells: 240 nCPM
- gastric chief cells: 170 nCPM
- enteric stem cells: 170 nCPM
Immune cell
- total PBMC: 535 nTPM
- plasmacytoid DC: 518 nTPM
- myeloid DC: 489 nTPM
- T-reg: 462 nTPM
- memory B-cell: 379 nTPM
- non-classical monocyte: 376 nTPM
Brain region
- thalamus: 700 nTPM
- hypothalamus: 683 nTPM
- pons: 662 nTPM
- medulla oblongata: 634 nTPM
- cerebellum: 610 nTPM
- cerebral cortex: 602 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about COX6A1.
Disease | AllUniProt
Conditions COX6A1 is implicated in, by any mechanism.
- Charcot-Marie-Tooth disease, recessive intermediate D (CMTRID) MIM:616039
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 118 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Charcot-Marie-Tooth disease recessive intermediate D
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.76
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.42
- DepMap mean gene effect
- -0.56
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular respiration
- generation of precursor metabolites and energy
- mitochondrial electron transport, cytochrome c to oxygen
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads COX6A1 as an antibody target. Whether an autoantibody or antibody against COX6A1 could matter depends on whether native COX6A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
COX6A1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label COX6A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...